Monocyte-derived growth factors in asbestos-induced interstitial fibrosis.
Asbestos-induced pulmonary fibrosis is thought to result from a series of cellular interactions involving the alveolar macrophage and the lung fibroblast. Although a dose-response relation has been established between asbestos exposure and the development of interstitial fibrosis, the majority of workers exposed even to high concentrations of asbestos do not develop radiographically evident interstitial fibrosis. As a means of understanding the pathogenesis of asbestos-induced fibrosis and the differential host response to the asbestos fiber, we studied the production of monocyte-derived growth factors in subjects with asbestosis (N = 5) and normal exposure-matched controls (N = 5). Under unstimulated culture conditions, the conditioned medium (CM) from monocytes from control subjects had a greater proliferative effect on fibroblasts than monocyte CM from patients with asbestosis. With CM from concanavalin A-stimulated monocytes, the proliferative response of the fibroblast was similar in those with asbestosis and control subjects. Freshly isolated monocytes from both normal subjects and patients with asbestosis did not express the gene for the B chain of platelet-derived growth factor (PDGF) as evaluated by hybridization with a PDGF-specific human cDNA probe. After 20 hr of culture in concanavalin A, monocytes from normal subjects expressed the gene for the B chain of PDGF while, under the same culture conditions, none of the monocyte preparations from patients with asbestosis produced mRNA for this growth factor. These data indicate that peripheral blood monocytes from patients with asbestosis compared to exposure-matched controls have a reduced capacity to produce growth factor activity as measured by mitogenic activity and mRNA levels for the B chain of PDGF. These results suggest that peripheral blood monocytes from patients with asbestosis may comprise a less mature population of cells compared to exposure-matched controls.
Schwartz
D A
DA
Pulmonary and Critical Care Medicine Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Rosenstock
L
L
Clark
J G
JG
D000818:Animals; D001194:Asbestos / Q000009:adverse effects*; D001195:Asbestosis / Q000097:blood; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D006133:Growth Substances / Q000097:blood* / Q000302:isolation & purification / Q000494:pharmacology; D006801:Humans; D051379:Mice; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism*; D009693:Nucleic Acid Hybridization; D009784:Occupational Diseases / Q000097:blood / Q000209:etiology*; D011658:Pulmonary Fibrosis / Q000097:blood / Q000209:etiology*; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D012016:Reference Values
D006133:Growth Substances; D001194:Asbestos; D012313:RNA